4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000131
Options or other derivatives
- SVP, Specialty Commercial acquired 163,159 shares (grant or award)
- SVP, Specialty Commercial returned 163,159 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Todisco Joseph SVP, Specialty Commercial | 2019-11-13 | Returned to the company · Stock Option | −72,661 | 0 | D: show line 1 in the form | |||||
| Todisco Joseph SVP, Specialty Commercial | 2019-11-13 | Grant or award · Stock Option | +72,661 | 72,661 | D: show line 2 in the form | |||||
| Todisco Joseph SVP, Specialty Commercial | 2019-11-13 | Returned to the company · Stock Option | −90,498 | 0 | D: show line 3 in the form | |||||
| Todisco Joseph SVP, Specialty Commercial | 2019-11-13 | Grant or award · Stock Option | +90,498 | 90,498 | D: show line 4 in the form |
Loading xslF345X03/wf-form4_157377043282006.xml…